Snapshot from Jul 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Immunic to Participate in Investor...
Business investor conference participation

Immunic to Participate in Investor Conferences

Analysis based on 9 articles · First reported Jul 09, 2026 · Last updated Jul 09, 2026

Sentiment
0
Attention
0
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

This event is a routine investor relations activity with minimal direct market impact. It may provide a platform for Immunic to update investors on its clinical progress, but no material news is expected.

Biotechnology
Event Summary

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company developing oral therapies for neurologic diseases, announced its participation in three investor conferences in July 2026. The conferences include the Leerink Partners Therapeutics Forum (July 14-15 in Boston), the B. Riley Financial — B. Riley Securities Mind, Muscle & Vision Summit (July 16 in Boston), and the LifeSci Capital SF Biotech Forum (July 23 in San Francisco). Key executives such as CEO Ockelbo-Lundgren, President and COO Jason Tay, Chief Medical Officer Michael A. Panzara, and VP of IR Jessica Breu will attend and hold one-on-one meetings and a fireside chat. The company's lead program, vidofludimus calcium (IMU-838), is in Phase 3 trials for relapsing multiple sclerosis with top-line data expected by end of 2026.

Key Actions
20 Immunic announced participation
Entities Involved
stock
Immunic
Immunic is the company announcing its participation in investor conferences, which is a standard practice to engage with investors and analysts.
Importance 100.0 Sentiment 0.0
per
Ockelbo-Lundgren
CEO Ockelbo-Lundgren will attend the conferences and participate in meetings and a fireside chat, representing Immunic.
Importance 50.0 Sentiment 0.0
per
Jason Tay
President and COO Jason Tay will attend the conferences and participate in meetings and a fireside chat.
Importance 40.0 Sentiment 0.0
per
Michael A. Panzara
Chief Medical Officer Michael A. Panzara will attend the conferences and participate in meetings and a fireside chat.
Importance 40.0 Sentiment 0.0
per
Jessica Breu
VP of Investor Relations Jessica Breu will attend the conferences and coordinate meetings.
Importance 30.0 Sentiment 0.0
priv
Leerink Partners
Leerink Partners is hosting the Therapeutics Forum where Immunic will have one-on-one meetings.
Importance 20.0 Sentiment 0.0
subs
B. Riley Financial — B. Riley Securities
B. Riley Financial — B. Riley Securities is hosting the Mind, Muscle & Vision Summit where Immunic will present a fireside chat and hold meetings.
Importance 20.0 Sentiment 0.0
priv
LifeSci Capital
LifeSci Capital is hosting the SF Biotech Forum where Immunic will attend.
Importance 20.0 Sentiment 0.0
priv
LifeSci Advisors
LifeSci Advisors is listed as US IR contact for Immunic.
Importance 10.0 Sentiment 0.0
priv
KCSA Strategic Communications
KCSA Strategic Communications is listed as US media contact for Immunic.
Importance 10.0 Sentiment 0.0
per
Joyce Allaire
Joyce Allaire is the contact at LifeSci Advisors for Immunic.
Importance 10.0 Sentiment 0.0
per
Caitlin Kasunich
Caitlin Kasunich is the contact at KCSA Strategic Communications for Immunic.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.